Financhill
Back

Medicenna Therapeutics Corp. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
12

MDNA.TO
Medicenna Therapeutics Corp.

Last Price:
$0.94
Seasonality Move:
-1.47%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDNA.TO is experiencing selling pressure, which indicates risk of future bearish movement.

Medicenna Therapeutics Corp. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.04 Sell
20-day SMA: 1.33 Sell
50-day SMA: 1.34 Sell
200-day SMA: 1.07 Sell
8-day EMA: 1.07 Sell
20-day EMA: 1.23 Sell
50-day EMA: 1.26 Sell
200-day EMA: 0.78 Buy

Medicenna Therapeutics Corp. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 26.63 Sell
Chaikin Money Flow: -46717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.11 - 1.59) Sell
Bollinger Bands (100): (0.94 - 1.42) Sell

Medicenna Therapeutics Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Medicenna Therapeutics Corp. Stock

Is Medicenna Therapeutics Corp. Stock a Buy?

MDNA.TO Technical Analysis vs Fundamental Analysis

Sell
12
Medicenna Therapeutics Corp. (MDNA.TO) is a Sell

Is Medicenna Therapeutics Corp. a Buy or a Sell?

Medicenna Therapeutics Corp. Stock Info

Market Cap:
78.4M
Price in USD:
0.94
Share Volume:
70.1K

Medicenna Therapeutics Corp. 52-Week Range

52-Week High:
1.98
52-Week Low:
0.78
Sell
12
Medicenna Therapeutics Corp. (MDNA.TO) is a Sell

Medicenna Therapeutics Corp. Share Price Forecast

Is Medicenna Therapeutics Corp. Stock a Buy?

Fundamental Analysis of Medicenna Therapeutics Corp.

Is Medicenna Therapeutics Corp. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Medicenna Therapeutics Corp.

Should I short Medicenna Therapeutics Corp. stock?

* Medicenna Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.